News
See the latest PIR International News, Articles and Network Updates.
Thaminda Ramanayake – BioLeader Interview
Chief Executive Officer, Anaveon (May 2026) Thaminda Ramanayake has more than two decades of global biotechnology and pharmaceutical leadership experience, with a focus on building companies and advancing innovative therapeutics. Thaminda is currently Chief Executive Officer of Anaveon, a [...]
PIR International Supports Appointment of Chief Executive Officer at Anaveon
PIR International is delighted to announce its partnership with Anaveon, a late-stage preclinical biotech focused on reprogramming the immune system with precision biologics, in the appointment of Thaminda Ramanayake as its new Chief Executive Officer. Mr. Ramanayake brings over 20 [...]
PIR International Supports Appointment of VP Regulatory Affairs at Gilgamesh Pharmaceuticals
PIR International was delighted to partner with Gilgamesh Pharmaceuticals on the appointment of Bridget Walton as VP Regulatory Affairs. Gilgamesh Pharmaceuticals is a clinical-stage neuroscience biotech developing innovative, best-in-class new chemical entities (NCEs) that transform the treatment paradigm of psychiatric [...]
PIR International Supports Appointment of VP of Clinical Development at Maxion Therapeutics
PIR International was thrilled to partner with Maxion Therapeutics on the appointment of Helen Timmis as VP of Clinical Development. Maxion Therapeutics (Maxion) is developing a pipeline of potentially first and best-in-class protein therapeutics using its proprietary KnotBody® technology. KnotBody® [...]